Mivacron (Mivacurium Chloride)

Mivacurium chloride, the active ingredient in Mivacron, is a non-depolarizing neuromuscular blocker presented as an injectable solution for intravenous use. It provides rapid, short‑acting skeletal muscle relaxation to facilitate endotracheal intubation and to support surgical procedures.

GNH USA supplies Mivacron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients include tertiary care centers, surgical suites, and anesthesia departments seeking consistent supply of high‑purity neuromuscular blocking agents.

Mivacron is used as a short‑acting neuromuscular blocker to facilitate muscle relaxation in specific peri‑operative settings.

Facilitation of endotracheal intubation: provides a rapid onset of skeletal muscle relaxation that allows clinicians to place an endotracheal tube quickly and safely. Muscle relaxation during surgery: maintains adequate paralysis for optimal surgical conditions and improves operative field exposure. Adjunct for mechanical ventilation: supports controlled ventilation in intensive‑care settings by providing reliable, short‑duration muscle relaxation.

Mivacron may be associated with a range of adverse reactions following intravenous administration.

Common Side Effects: - Transient flushing or erythema at the injection site - Mild hypotension - Transient tachycardia - Bronchospasm, particularly in susceptible individuals

Serious or Rare Side Effects: - Prolonged neuromuscular blockade requiring extended ventilation support - Anaphylactic reaction with potential airway compromise - Severe hypotension or cardiovascular collapse - Hyperkalemia (rare occurrence)

When using Mivacron, clinicians should observe specific safety measures.

Dose adjustment: consider reduced dosing in patients with hepatic impairment. Monitoring: continuous neuromuscular transmission monitoring is recommended during use. Allergy: avoid in patients with known hypersensitivity to mivacurium or related compounds. Drug interactions: be cautious when used with other neuromuscular blocking agents. Pregnancy: use only if the potential benefit justifies the unknown risk. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Mivacron can interact with several agents that modify neuromuscular transmission.

Major Interactions (Avoid): - Aminoglycoside antibiotics: potentiate neuromuscular blockade. - Lithium: may enhance muscle relaxation. - Magnesium sulfate: synergistic effect leading to prolonged paralysis.

Moderate Interactions (Monitor Closely): - Volatile anesthetics (e.g., sevoflurane): increase block duration. - Inhalational agents (nitrous oxide): may augment the effect. - Other non‑depolarizing blockers: additive neuromuscular depression.